Home
Conditions
Peritoneal Carcinomatosis

Clinical trial condition

Peritoneal Carcinomatosis

Explore clinical trials studying Peritoneal Carcinomatosis. Study availability and eligibility vary by location and protocol.

84 public trials 25 recruiting studies

Refine in advanced search Browse all conditions

Peritoneal Carcinomatosis trial results

Recruiting

Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed

NCT01617382

Conditions: Abdominal Neoplasms, Adenocarcinoma, Adenocarcinoma, Mucinous, +17 more
Locations: University Clinics Gasthuisberg Leuven, Flemish Brabant, Belgium

View Trial Details

Recruiting

Complete Cytoreduction Followed by IP and Systemic Chemotherapies for Gastric Cancer With Peritoneal Carcinomatosis

NCT04547725

Conditions: Abdominal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Recruiting

Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer Patients

NCT03280511

Conditions: Abdominal Neoplasms, Colo-rectal Cancer, Colonic Diseases, +15 more
Locations: Odense PIPAC Center, Department of Surgery, Odense University Hospital Odense, Denmark

View Trial Details

Recruiting

Longitudinal Study of CRS/HIPEC for Peritoneal Carcinomatoses

NCT04108936

Conditions: Abdominal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +5 more
Locations: Krankenhaus der Barmherzigen Brüder Regensburg Regensburg, Bavaria, Germany

University Hospital Regensburg Regensburg, Germany

View Trial Details

Recruiting

Oncological Benefits of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients With T3-4 Gastric Cancer Cyt-

NCT04595929

Conditions: Abdominal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: First Pavlov State Medical University of St. Petersburg Saint Petersburg, Russia

View Trial Details

Not Yet Recruiting

MRI-Guided Adaptive Radiotherapy for Limited Peritoneal Metastases (MARACAS Trial).

NCT07593261

Conditions: Abdominal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +7 more
Locations: Gemelli ART (Advanced Radiation Therapy)-Fondazione Policlinico Universitario Agostino Gemelli IRCCS Roma, Italy

View Trial Details

Not Yet Recruiting

Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors

NCT07487168

Conditions: Abdominal Neoplasms, Appendiceal Neoplasms, Cecal Diseases, +15 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Completed

Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis

NCT05185947

Conditions: Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +43 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Olvi-Vec Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian Cancer

NCT02759588

Conditions: Abdominal Neoplasms, Adnexal Diseases, Carcinoma, +30 more
Locations: Gynecologic Oncology Associates Newport Beach, California, United States

AdventHealth Cancer Institute Orlando, Florida, United States

View Trial Details

Completed

Study of Radspherin® in Recurrent Ovarian Cancer Subjects With Peritoneal Carcinomatosis

NCT03732768

Conditions: Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +19 more
Locations: UZ Leuven Leuven, Belgium

The Norwegian Radiumhospital Oslo, Norway

Clínica Universidad de Navarra Madrid, Spain

Clínica Universidad de Navarra Pamplona, Spain

View Trial Details

Peritoneal Carcinomatosis

Peritoneal Carcinomatosis trial results

Related conditions